EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands

Ann E Cleves iD, Himani Tandon iD, Ajay N Jain iD

Journal of Computer-Aided Molecular Design · 2024

DOI: 10.1007/s10822-024-00574-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Computer-Aided Molecular Design, 2024. Verfasst von Ann E Cleves und 2 weiteren Autor:innen. Beteiligte Einrichtung: BioPharmics Division, Optibrium Limited, Cambridge, CB25 9PB, UK. Hauptthemen laut MEDLINE: Macrocyclic Compounds, Molecular Docking Simulation, Protein Binding, Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

So-called "cross-docking" is the prediction of the bound configuration of small-molecule ligands that differ from the cognate ligand of a protein co-crystal structure. This is a much more challenging problem than re-docking the cognate ligand, particularly when the new ligand is structurally dissimilar from prior known ones. We have updated the previously introduced PINC ("PINC Is Not Cognate") benchmark which introduced the idea of temporal segregation to measure cross-docking performance. The temporal set encompasses 846 future ligands for ten targets based on information from the earliest 25% of X-ray co-crystal structures known for each target. Here, we extend the benchmark to include thirteen targets where the bound poses of 128 macrocyclic ligands are to be predicted based on knowledge from structures of bound non-macrocyclic ligands. Performance was roughly equivalent for both the temporally-split non-macrocyclic ligand set and the macrocycle prediction set. Using standard and fully automatic protocols for the Surflex-Dock and ForceGen methods, across the combined 974 non-macrocyclic and macrocyclic ligands, the top-scoring pose family was correct 68% of the time, with the top-two pose families achieving a 79% success rate. Correct poses among all those predicted were identified 92% of the time. These success rates far exceeded those observed for the alternative methods AutoDock Vina and Gnina on both sets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macrocyclic CompoundsMolecular Docking SimulationProtein BindingProteinsLigandsCrystallography, X-RayBinding SitesProtein ConformationDrug Design

Stichwörter der Autor:innen

AutoDockDockingForceGenGninaMacrocycleSurflex-DockVinaxGen

Substanzen

LigandsMacrocyclic CompoundsProteins

Autor:innen und Institutionen

  • BioPharmics Division, Optibrium Limited, Cambridge, CB25 9PB, UK.
  • Research Department, Optibrium Limited, Cambridge, CB25 9PB, UK.
  • BioPharmics Division, Optibrium Limited, Cambridge, CB25 9PB, UK. ajay@optibrium.com.

ORCID-Profile: Ann E Cleves, Himani Tandon, Ajay N Jain

Zitieren

APA

Cleves, A. E., Tandon, H., & Jain, A. N. (2024). Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands. Journal of Computer-Aided Molecular Design. https://doi.org/10.1007/s10822-024-00574-0

Vancouver

Cleves AE, Tandon H, Jain AN. Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands. Journal of Computer-Aided Molecular Design. 2024. doi:10.1007/s10822-024-00574-0

BibTeX
@article{Cleves2024,
  author = {Cleves, Ann E and Tandon, Himani and Jain, Ajay N},
  title = {Structure-based pose prediction: Non-cognate docking extended to macrocyclic ligands},
  journal = {Journal of Computer-Aided Molecular Design},
  year = {2024},
  doi = {10.1007/s10822-024-00574-0}
}
Kostenlos starten →